Status:
ACTIVE_NOT_RECRUITING
Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 Diabetes
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Karolinska University Hospital
Conditions:
Type 1 Diabetes Mellitus
Parent-Child Relations
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study investigates feasibility and preliminary effects of a new behavioral parent intervention that aims to support and improve pediatric diabetes self-management
Detailed Description
Diabetes self-management is extensive, complex and places high demands on the affected individual and his/her family. Today, half of Swedish children and adolescents with type 1 diabetes (T1D) do not ...
Eligibility Criteria
Inclusion
- Parents/guardians of children aged 9-14 with type 1 diabetes.
- The child has had type 1 diabetes for at least one year.
- The parent experience difficulties in managing daily life and/or the parent-child collaboration around self-management routines.
- The perceived difficulties should not solely be due to perceived problems in the medical aspects of the diabetes treatment, such as a perceived need for more support in insulin dosing, more diabetes education, or technical/medical support. This criterion is based solely on the subjective judgement of the parent him-/herself.
- The child receives diabetes care at one of the three diabetes clinics in the Stockholm Region.
- The parent speaks, understands, and can read Swedish.
- The parent claims to be motivated and has the practical possibility to participate in the study and attend group meetings.
Exclusion
- The parent reports current and severe psychiatric conditions in themselves or the child that need to be prioritized, such as severe depression, suicidal thoughts/self-harm, psychosis, or mania.
- The parent is involved in another psychological treatment of a behavior-changing nature that is in an active phase, either concerning themselves or a child.
- Major planned changes in diabetes treatment that require learning and behavioral changes, such as transitioning from pen to pump, and that are expected to occur during the first 3.5 months of the study (active intervention phase).
Key Trial Info
Start Date :
September 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2025
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT06599840
Start Date
September 20 2024
End Date
November 1 2025
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 17164